Non-Disclosure of a Pregnant Woman's HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission.
Summary of "Non-Disclosure of a Pregnant Woman's HIV Status to Her Partner is Associated with Non-Optimal Prevention of Mother-to-Child Transmission."
Our objective was to study relations between non-disclosure of HIV to partner, socio demographics and prevention of HIV mother-to-child transmission (PMTCT), among HIV-infected pregnant women enrolled in the French Perinatal Cohort (ANRS-EPF-CO1) from 2005 to 2009 (N = 2,952). Fifteen percent of the women did not disclose their HIV status to their partner. Non-disclosure was more frequent in women diagnosed with HIV infection late in pregnancy, originating from Sub-Saharan Africa or living alone, as well as when the partner was not tested for HIV. Non-disclosure was independently associated with non optimal
late initiation of antiretroviral therapy, detectable viral load at delivery and lack of neonatal prophylaxis. Nonetheless, the rate of transmission did not differ according to disclosure status. Factors associated with non-disclosure reflect vulnerability and its association with non optimal PMTCT is a cause for concern although the impact on transmission was limited in this context of universal free access to care.
INSERM, UMRS 1018, CESP-HIV/IST Epidemiology, Le Kremlin-Bicêtre, France, email@example.com.
This article was published in the following journal.
Name: AIDS and behavior
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22130651
- DOI: http://dx.doi.org/10.1007/s10461-011-0084-y
Sub-Saharan Africa has continued to bear the greatest burden of HIV/AIDS epidemic in the world. Partner disclosure of status may create opportunities for support or rejection.
Women's ability to safely disclose their HIV-positive status to male partners is essential for uptake and continued use of prevention of mother-to-child transmission (PMTCT) services. However, little...
Iodine deficiency disorders (IDD) are widespread in China. Presently, IDD have been put under control by Universal Salt Iodisation (USI) in China; however, there is a lack of evidence on whether the i...
For many employees with multiple sclerosis (MS), disclosure of their diagnosis at work is seen as a high-risk strategy that might lead to diminished perceptions of their capabilities by supervisors an...
Woman abuse varies across intimate relationship categories (e.g., marriage, divorce, separation). However, it is unclear whether relationship status variations in violence against women differ across...
The long-range goal of this research is to develop better ways of helping GI cancer patients and their caregivers cope more effectively with the demands of the disease. The study is desig...
Ribavirin should be avoided during pregnancy and during the 6 months before pregnancy in both the female and the male sexual partner. If a pregnancy occurs and is reported to the Ribaviri...
This study will examine the ways in which people reveal their status as a carrier of Huntington's disease (HD) or of being at risk for the disease. It will explore factors that influence d...
The aims are to evaluate: (1) the effectiveness of written self-disclosure (WSD) on health status of youth ages 12-18 with functional recurrent abdominal pain (RAP); (2) whether effectiven...
DOVE Home Visit Program is a brochure based intervention delivery by public health nurses which aims to prevent and reduce intimate partner violence against pregnant and postpartum women a...
Medical and Biotech [MESH] Definitions
The bond or lack thereof between a pregnant woman and her FETUS.
Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)
Surgery performed on the pregnant woman for conditions associated with pregnancy, labor, or the puerperium. It does not include surgery of the newborn infant.
Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.
The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.